Skip to NavigationSkip to content

News

The FDA has announced the approval of Mylan’s Ogivri, the first biosimilar version of Roche’s Herceptin to be authorised for use in the US. The drug...
As part of Johnson & Johnson’s acquisition of Actelion, it was able to secure a number of ties with the spinout from the deal, Idorsia. The big...
Pfizer's Viagra Connect becomes first over-the-counter erectile dysfunction treatment in UK and the UK Government announces massive investments from...
Scott Gottlieb, FDA commissioner, was speaking in front of the House Committee on Energy and Commerce, regarding the 21st Century Cures Act, when he...
The FDA has announced the approval of the first and only once-monthly buprenorphine injection for the treatment of moderate-to-severe opioid use...
New research published in The Lancet has revealed that type 1 diabetes cannot be understood as a “disease of the childhood” as 42% of those...
Novartis has released new data for Consentyx (secukinumab) which it claims make the IL-17A inhibitor “the first biologic to show long-term efficacy...
The FDA has announced its approval of AliveCor’s Kardia Band, an electrocardiogram for use with the Apple Watch, marking the first authorisation of...
After analysing six years’ worth of data on its dengue vaccine, Dengvaxia, Sanofi contacted health authorities to tell them that its vaccine posed a...
Descriptions of treatments as ‘revolutionary’ or ‘ground-breaking’ are ten a penny in the pharmaceutical industry, very rarely do such treatments...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches